R
Ryan C. Maves
Researcher at Naval Medical Center San Diego
Publications - 137
Citations - 1772
Ryan C. Maves is an academic researcher from Naval Medical Center San Diego. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 19, co-authored 99 publications receiving 1140 citations. Previous affiliations of Ryan C. Maves include Naval Medical Research Center & Uniformed Services University of the Health Sciences.
Papers
More filters
Journal ArticleDOI
Triage of Scarce Critical Care Resources in COVID-19 An Implementation Guide for Regional Allocation: An Expert Panel Report of the Task Force for Mass Critical Care and the American College of Chest Physicians.
Ryan C. Maves,James Downar,Jeffrey R. Dichter,John L. Hick,Asha V. Devereaux,James A. Geiling,Niranjan Kissoon,Nathaniel Hupert,Alexander S. Niven,Mary A. King,Lewis Rubinson,Dan Hanfling,James G. Hodge,Mary Faith Marshall,Katherine Fischkoff,Laura Evans,Mark R. Tonelli,Randy S. Wax,Gilbert Seda,John S. Parrish,Robert D. Truog,Charles L. Sprung,Michael D. Christian +22 more
TL;DR: The principles of tertiary triage and methods for implementing such a system are discussed, emphasizing that these systems should serve only as a last resort.
Journal ArticleDOI
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial.
Andre C. Kalil,Aneesh K. Mehta,Thomas F Patterson,Nathaniel B. Erdmann,Carlos A. Gomez,Mamta K. Jain,Cameron R. Wolfe,Guillermo M. Ruiz-Palacios,Susan Kline,Justino Regalado Pineda,Anne F Luetkemeyer,Michelle Harkins,Patrick E. H. Jackson,Nicole M. Iovine,Victor F. Tapson,Myoung Don Oh,Jennifer A Whitaker,Richard A. Mularski,Catharine I. Paules,Dilek Ince,Jin Takasaki,Daniel A. Sweeney,Uriel Sandkovsky,David L. Wyles,Elizabeth L. Hohmann,Kevin Grimes,Robert Grossberg,Maryrose Laguio-Vila,Allison A Lambert,Diego Lopez de Castilla,Eu-Suk Kim,LuAnn Larson,Claire Ramsay Wan,Jessica Traenkner,Philip O Ponce,Jan E Patterson,Paul A. Goepfert,Theresa A. Sofarelli,Satish Mocherla,Emily R Ko,Alfredo Ponce de Leon,Sarah B Doernberg,Robert L. Atmar,Ryan C. Maves,Fernando Dangond,Jennifer Ferreira,Michelle Green,Mat Makowski,Tyler Bonnett,Tatiana Beresnev,Varduhi Ghazaryan,Walla Dempsey,Seema U Nayak,Lori E. Dodd,Kay M. Tomashek,John H. Beigel +55 more
TL;DR: In this article, the authors compared the efficacy of interferon beta-1a in combination with remdesivir in hospitalised patients with SARS-CoV-2 infection, as confirmed by a positive RT-PCR test, and the primary outcome was time to recovery, defined as the first day that a patient attained a category 1, 2, or 3 score on the eight-category ordinal scale.
Journal ArticleDOI
Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial.
John H. Beigel,Evgenia Aga,Marie-Carmelle Elie-Turenne,Josalyn L. Cho,Pablo Tebas,Carol L. Clark,Jordan P. Metcalf,Caroline P. Ozment,Kanakatte Raviprakash,Joy Beeler,H Preston Holley,Stephanie Warner,Carla Chorley,H. Clifford Lane,Michael Hughes,Richard T. Davey,Michelle A. Barron,Aveh Bastani,Philippe R. Bauer,William Borkowsky,Charles B. Cairns,Jaime G. Deville,Marie-Carmelle Elie,Carl J. Fichtenbaum,Robert W. Finberg,Mamta K. Jain,David Kaufman,Michael Z. Lin,John Lin,Ryan C. Maves,Lee E. Morrow,Minh-Hong Nguyen,Pauline Park,Christopher Polk,Adrienne G. Randolph,Suchitra Rao,Lewis Rubinson,Christina Schofield,Shmuel Shoham,Erika Stalets,Renee D Stapleton +40 more
TL;DR: This randomised, double-blind, phase 3 trial at 41 US medical centres to assess the efficacy of high-titre anti-influenza plasma (haemagglutination inhibition antibody titre ≥1:80) compared with standard low-Titre plasma to improve outcomes in patients with severe influenza A infection showed low conditional power.
Journal ArticleDOI
Campylobacter antimicrobial resistance in Peru: a ten-year observational study
Simon Pollett,Claudio Rocha,Rito Zerpa,Lilian Patiño,Augusto Valencia,Máximo Camiña,José Guevara,Martha Lopez,Nancy Chuquiray,Eduardo Salazar-Lindo,Carlos Calampa,Martín Casapia,Rina Meza,Maruja Bernal,Drake H. Tilley,Michael J. Gregory,Ryan C. Maves,Eric W. Hall,Franca R. Jones,C Sofia Arriola,Marieke Rosenbaum,Juan Perez,Matthew R. Kasper +22 more
TL;DR: The prevalence trends of fluoroquinolone and macrolide-resistant C. jejuni and C. coli stool isolates from three regions in Peru over a ten-year period have implications for the empirical management of enterocolitis in Peru.
Journal ArticleDOI
Persistent Low-level Viremia While on Antiretroviral Therapy Is an Independent Risk Factor for Virologic Failure
Christie Joya,Christie Joya,Seung Hyun Won,Seung Hyun Won,Christina Schofield,Christina Schofield,Tahaniyat Lalani,Tahaniyat Lalani,Tahaniyat Lalani,Ryan C. Maves,Ryan C. Maves,Karl Kronmann,Karl Kronmann,Robert Deiss,Jason F. Okulicz,Jason F. Okulicz,Brian K. Agan,Brian K. Agan,Anuradha Ganesan,Anuradha Ganesan,Anuradha Ganesan +20 more
TL;DR: The data adds to the body of evidence that suggests persistent LLV is associated with deleterious virologic consequences.